"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 26 | 26 |
| 1997 | 0 | 22 | 22 |
| 1998 | 0 | 30 | 30 |
| 1999 | 0 | 35 | 35 |
| 2000 | 0 | 53 | 53 |
| 2001 | 0 | 31 | 31 |
| 2002 | 0 | 26 | 26 |
| 2003 | 1 | 51 | 52 |
| 2004 | 0 | 55 | 55 |
| 2005 | 0 | 65 | 65 |
| 2006 | 0 | 47 | 47 |
| 2007 | 0 | 73 | 73 |
| 2008 | 1 | 87 | 88 |
| 2009 | 1 | 85 | 86 |
| 2010 | 0 | 90 | 90 |
| 2011 | 0 | 121 | 121 |
| 2012 | 0 | 123 | 123 |
| 2013 | 0 | 140 | 140 |
| 2014 | 1 | 121 | 122 |
| 2015 | 1 | 148 | 149 |
| 2016 | 1 | 135 | 136 |
| 2017 | 2 | 147 | 149 |
| 2018 | 4 | 147 | 151 |
| 2019 | 1 | 176 | 177 |
| 2020 | 1 | 148 | 149 |
| 2021 | 1 | 109 | 110 |
| 2022 | 0 | 56 | 56 |
| 2023 | 0 | 64 | 64 |
| 2024 | 0 | 108 | 108 |
| 2025 | 0 | 79 | 79 |
| 2026 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Measuring Hypothyroidism Disease Control Using a TSH-based "Time-in-range". J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e484-e492.
-
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data. Clin Cancer Res. 2026 Jan 16; 32(2):428-437.
-
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. Blood Adv. 2026 Jan 13; 10(1):217-227.
-
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with =5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026 Jan 01; 132(1):e70210.
-
K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy. J Appl Clin Med Phys. 2026 Jan; 27(1):e70439.
-
Contemporary data in myeloproliferative neoplasm-unclassifiable: mutational landscape and management of the 'unclassifiable'. Curr Opin Hematol. 2026 Mar 01; 33(2):45-50.
-
Characterizing Disparities in Access to Surgery for Pituitary Adenomas: A National Cancer Database Analysis. J Clin Endocrinol Metab. 2025 Nov 18; 110(12):e4188-e4195.
-
Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis. J Natl Cancer Inst. 2025 Nov 01; 117(11):2388-2393.
-
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications. Am J Clin Pathol. 2025 Oct 04; 164(4):530-544.
-
The association of place-based disadvantage and access to deceased donor heart transplantation. Am J Transplant. 2026 Feb; 26(2):393-403.